跳至主要内容
临床试验/NCT01439399
NCT01439399已完成不适用

Analgesic Efficacy of Intravenous Perfusion of Lidocaine, Ketamine or a Combination After Laparotomy in a Placebo-controlled, Randomized, Double-blind Prospective Study

University of Lausanne Hospitals1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2005年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52
试验地点
1
主要终点
Cumulative morphine consumption

研究概览

简要总结

The aim of the present study is to evaluate the analgesic benefit of intravenous lidocaine and ketamine in the perioperative period of abdominal surgery.

详细描述

Optimal postoperative pain management facilitates rehabilitation immediately after abdominal surgery. Multiple studies have demonstrated that successful postoperative analgesia also reduces perioperative complications and improves patient comfort, thereby providing many benefits for the patient. In acute postoperative pain management intravenous lidocaine and/or ketamine have been advocated because of their morphine-sparing effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • abdominal surgery by laparotomy

排除标准

  • laparoscopy
  • history of chronic pain
  • opioid self-administration
  • psychiatric disorders
  • difficulties with communication
  • renal or hepatic dysfunction
  • ASA physical status > 3

研究组 & 干预措施

Lidocaine

Active Comparator

Intravenous lidocaine administered preoperatively (anesthesia induction) and postoperatively during 48 hours

干预措施: Lidocaine, (Drug)

Ketamine

Active Comparator

Intravenous ketamine administered preoperatively (anesthesia induction) and postoperatively during 48 hours

干预措施: Ketamine (Drug)

Ketamine-Lidocaine

Active Comparator

Intravenous association of ketamine and lidocaine administered preoperatively (at anesthesia induction) and postoperatively during 48 hours.

干预措施: association ketamine-lidocaine (Drug)

Saline 0,9%

Placebo Comparator

Control group

干预措施: Placebo (Drug)

结局指标

主要结局

Cumulative morphine consumption

时间窗: 48 hours

Cumulative morphine consumption over 48 hours postoperatively

次要结局

  • Pain scores(48 hours)
  • Mechanical hyperalgesia(48 hours)
  • Occurrence of side effects(48 hours)

研究者

发起方
University of Lausanne Hospitals
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joray Florence

Chief Resident

University of Lausanne Hospitals

研究点 (1)

Loading locations...

相似试验